IRIS
SALVATORE, Giuliana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.528
EU - Europa 4.007
AS - Asia 1.084
SA - Sud America 188
Continente sconosciuto - Info sul continente non disponibili 20
AF - Africa 16
OC - Oceania 4
Totale 11.847
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.505
RU - Federazione Russa 1.549
UA - Ucraina 673
IT - Italia 394
VN - Vietnam 379
SG - Singapore 357
SE - Svezia 344
GB - Regno Unito 301
DE - Germania 289
CN - Cina 246
FR - Francia 167
BR - Brasile 166
FI - Finlandia 92
NL - Olanda 80
HK - Hong Kong 23
PL - Polonia 22
EU - Europa 19
AT - Austria 18
BE - Belgio 15
IN - India 15
CA - Canada 14
IE - Irlanda 13
CZ - Repubblica Ceca 12
JP - Giappone 9
TR - Turchia 9
AR - Argentina 8
PK - Pakistan 7
ZA - Sudafrica 6
MX - Messico 5
PT - Portogallo 5
BG - Bulgaria 4
ES - Italia 4
IL - Israele 4
KR - Corea 4
RO - Romania 4
SA - Arabia Saudita 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
EC - Ecuador 3
MA - Marocco 3
PE - Perù 3
UZ - Uzbekistan 3
AM - Armenia 2
AU - Australia 2
BD - Bangladesh 2
CH - Svizzera 2
CO - Colombia 2
DK - Danimarca 2
EG - Egitto 2
GR - Grecia 2
HU - Ungheria 2
LK - Sri Lanka 2
LV - Lettonia 2
MY - Malesia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PY - Paraguay 2
RS - Serbia 2
SN - Senegal 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
VE - Venezuela 2
AL - Albania 1
BH - Bahrain 1
BT - Bhutan 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
HR - Croazia 1
IQ - Iraq 1
IR - Iran 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LT - Lituania 1
MC - Monaco 1
MK - Macedonia 1
NO - Norvegia 1
NP - Nepal 1
PA - Panama 1
PH - Filippine 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 11.847
Salva come PNG Salva come JPEG
Città #
Fairfield 965
Woodbridge 707
Houston 587
Chandler 454
Ann Arbor 444
Ashburn 409
Seattle 395
Dong Ket 377
Wilmington 377
Cambridge 327
Moscow 272
Nyköping 220
Singapore 208
Dearborn 207
The Dalles 195
Jacksonville 177
Boardman 157
Southend 146
Naples 105
Napoli 76
Beijing 72
Princeton 70
Lawrence 64
Groningen 63
Grafing 59
Yubileyny 58
New York 55
Ogden 52
Munich 43
Shanghai 40
San Diego 36
Helsinki 33
Düsseldorf 26
Los Angeles 26
Des Moines 24
Formia 23
Milan 23
Hong Kong 22
London 19
Jinan 17
Norwalk 17
Lauterbourg 15
Brussels 14
Hefei 14
Kunming 13
São Paulo 13
Boydton 12
Dallas 12
Auburn Hills 11
Dublin 11
Frankfurt am Main 11
Kraków 11
Vienna 11
Nanjing 10
Redmond 9
Tokyo 9
Afragola 8
Amsterdam 8
Bremen 8
Edinburgh 8
Nocera Inferiore 8
Redwood City 8
Rome 8
Santa Clara 8
Atlanta 7
Brno 7
Warsaw 7
Shenyang 6
Turku 6
Casoria 5
Guangzhou 5
Kilburn 5
Nanchang 5
Nocera Superiore 5
Nuremberg 5
St Louis 5
Stockholm 5
Bexley 4
Chicago 4
Hangzhou 4
Matawan 4
Portsmouth 4
Recife 4
Rio de Janeiro 4
Shenzhen 4
Zhengzhou 4
Altavilla Irpina 3
Baku 3
Boston 3
Charlotte 3
Chongqing 3
Costa Mesa 3
Fuzhou 3
Giugliano in Campania 3
Hanover 3
Jundiaí 3
Kocaeli 3
Lisbon 3
Mexico City 3
Montreal 3
Totale 8.038
Salva come PNG Salva come JPEG
Nome #
Extracellular superoxide dismutase is a thyroid differentiation marker down-regulated in cancer 321
TWIST1/miR-584/TUSC2 pathway induces resistance to apoptosis in thyroid cancer cells 281
Junctional adhesion molecule-A is down-regulated in anaplastic thyroid carcinomas and reduces cancer cell aggressiveness by modulating p53 and GSK3 α/β pathways 251
Unveiling the miRNAs responsive to physical activity/exercise training in cancer: A systematic review 248
A cell proliferation and chromosomal instability signature in anaplastic thyroid carcinoma 247
Biological role and potential therapeutic targeting of the chemokine receptor CXCR4 in undifferentiated thyroid cancer 244
Long-term recreational football training and health in aging 238
Anterior gradient protein 2 promotes survival, migration and invasion of papillary thyroid carcinoma cells 221
Imaging of thyroid tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice. 217
Anaplastic Thyroid Carcinoma: Molecular Tools for Diagnosis and Therapy 217
Cytostatic Activity of Adenosine Triphosphate-Competitive Kinase Inhibitors in BRAF Mutant Thyroid Carcinoma Cells 214
Identification of polo-like kinase 1 as a potential therapeutic target in anaplastic thyroid carcinoma 213
RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma 209
BAY 43-9006 inhibition of oncogenic RET mutants. 205
Multimodal imaging for a theranostic approach in a murine model of B-cell lymphoma with engineered nanoparticles 203
Preclinical Imaging for the Study of Mouse Models of Thyroid Cancer 200
miR-650 promotes motility of anaplastic thyroid cancer cells by targeting PPP2CA 198
The heterogeneous distribution of BRAF mutation supports the independent clonal origin of distinct tumor foci in multifocal papillary thyroid carcinoma 197
A set of miRNAs participates in the cellular senescence program in human diploid fibroblasts. 193
Analysis of BRAF Point Mutation and RET/PTC Rearrangement Refines the Fine-Needle Aspiration Diagnosis of Papillary Thyroid Carcinoma 192
YAP1 acts as oncogenic target of 11q22 amplification in multiple cancer subtypes 190
BRAF Is a Therapeutic Target in Aggressive Thyroid Carcinoma 189
Glial cell line-derived neurotrophic factor induces proliferative inhibition of NT2/D1 cells through RET-mediated up-regulation of the cyclin-dependent kinase inhibitor p27(kip1) 185
High-Frequency Ultrasound-Guided Injection for the Generation of a Novel Orthotopic Mouse Model of Human Thyroid Carcinoma 185
Induction of caspase-dependent programmed cell death in B-cell chronic lymphocytic leukemia by anti-CD22 immunotoxins 184
BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas 184
Identification of targets of twist1 transcription factor in thyroid cancer cells. 183
Receptor tyrosine kinase inhibitors in thyroid cancer 179
Different mutations of the RET gene cause different human tumoral diseases 179
Glial cell line-derived neutrotrophic factor and neurturin can act as paracrine growth factors stimulating DNA synthesis of Ret-expressing spermatogonia 178
BRAF mutations are not a major event in post-Chernobyl childhood thyroid carcinomas 176
Potent mitogenicity of the RET/PTC3 oncogene correlates with its prevalence in tall-cell variant of papillary thyroid carcinoma 172
Generation and characterization of novel monoclonal antibodies to the Ret receptor tyrosine kinase 172
DNA immunization followed by a single boost with cells: a protein-free immunization protocol for production of monoclonal antibodies against the native form of membrane proteins 169
Dissecting the molecular pathways involved in the effects of physical activity on breast cancers cells: A narrative review 169
The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells 165
Osteopontin is overexpressed in human papillary thyroid carcinomas and enhances thyroid carcinoma cell invasiveness 164
Only the substitution of methionine 918 with a threonine and not with other residues activates RET transforming potential 162
FOXM1 is a molecular determinant of the mitogenic and invasive phenotype of anaplastic thyroid carcinoma. 162
PATE, a gene expressed in prostate cancer, normal prostate, and testis, identified by a functional genomic approach 158
Identification of a novel subtype of H4-RET rearrangement in a thyroid papillary carcinoma and lymph node metastasis 158
Morphological ultrasound microimaging of thyroid in living mice 158
Tyrosines 1015 and 1062 are in vivo autophosphorylation sites in ret and ret-derived oncoproteins 157
MRP8, a new member of ABC transporter superfamily, identified by EST database mining and gene prediction program, is highly expressed in breast cancer 154
Novel candidate genes of thyroid tumourigenesis identified in Trk-T1 transgenic mice. 150
High Frequency Ultrasound for the development of an Orthotopic mouse model of Human Follicular Thyroid Carcinoma 149
Glial cell line-derived neurotrophic factor differentially stimulates ret mutants associated with the multiple endocrine neoplasia type 2 syndromes and Hirschsprung's disease 146
Low prevalence of BRAF mutations in radiation-induced thyroid tumors in contrast to sporadic papillary carcinomas 146
Presence of BRAF V600E in Very Early Stages of Papillary Thyroid Carcinoma 144
TWIST1 plays a pleiotropic role in determining the anaplastic thyroid cancer phenotype 143
Mitogenic effects of the up-regulation of MiniChromosome Maintenance proteins (MCM) in anaplastic thyroid carcinoma 139
Heterogeneity in the distribution of RET/PTC rearrangements within individual post-Chernobyl papillary thyroid carcinomas 138
Molecular profile of hyalinizing trabecular tumors of the thyroid: high prevalence of RET/PTC rearrangements and absence of B-raf and N-ras point mutations 136
Pros and cons of cellular studies in developing new drugs for thyroid cancers 135
Monitoring training in non-professional soccer players by coupling SSGs and GPS technology: effects of pitch size and players role 135
Molecular biology of the MEN2 gene 132
miR-622 Is a Novel Potential Biomarker of Breast Carcinoma and Impairs Motility of Breast Cancer Cells Through Targeting NUAK1 Kinase 131
Frequent mutation of PIK3CA in Anaplastic Thyroid Cancer 125
Improved cytotoxic activity toward cell lines and fresh leukemia cells of a mutant anti-CD22 immunotoxin obtained by antibody phage display 124
The different RET-activating capability of mutations of cysteine 620 or cysteine 634 correlates with the multiple endocrine neoplasia type 2 disease phenotype 121
Adiponectin and leptin exert antagonizing effects on proliferation and motility of papillary thyroid cancer cell lines 116
Regular football training down-regulates miR-1303 muscle expression in veterans 113
High prevalence of RET/PTC rearrangements in Ukrainian and Belarussia post-Chernobyl thyroid papillary carcinomas: a strong correlation between RET/PTC3 and the solid-follicular variant 109
Effects of Annurca Flesh Apple Polyphenols in Human Thyroid Cancer Cell Lines 106
RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes 99
The TUSC2 Tumour Suppressor Inhibits the Malignant Phenotype of Human Thyroid Cancer Cells via SMAC/DIABLO Protein 99
Evolution of intra-tumoral heterogeneity across different pathological stages in papillary thyroid carcinoma 96
miR-331-5p Affects Motility of Thyroid Cancer Cell Lines and Regulates BID Expression 94
Preclinical Imaging Evaluation of miRNAs' Delivery and Effects in Breast Cancer Mouse Models: A Systematic Review 86
The lncRNA TEX41 is upregulated in pediatric B-Cells Acute Lymphoblastic Leukemia and it is necessary for leukemic cell growth 71
Development of Cyclic Peptides Targeting the Epidermal Growth Factor Receptor in Mesenchymal Triple-Negative Breast Cancer Subtype 63
Exercise’s impact on lung cancer molecular mechanisms: a current overview 54
Insight into the Role of the miR-584 Family in Human Cancers 52
Association of radiomic features with genomic signatures in thyroid cancer: a systematic review. 44
Novel Biological Strategies for Melanoma Therapy: A Focus on lncRNAs and Their Targeting 20
Aberrant Expression of Non-Coding RNAs in Pediatric T Acute Lymphoblastic Leukemia and Their Potential Application as Biomarkers 10
Nanogel-Mediated Delivery of Doxorubicin and Curcumin in Thyroid Cancer Cells 10
Totale 12.077
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.963
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.963
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.740 104 140 173 123 147 85 148 51 74 154 50 491
2021/2022783 53 140 26 199 16 24 108 53 71 41 47 5
2022/20231.485 144 91 140 172 229 216 56 161 159 44 55 18
2023/2024390 29 29 34 23 11 48 19 14 79 23 26 55
2024/20252.981 60 230 36 60 34 293 624 987 148 114 306 89
2025/202695 95 0 0 0 0 0 0 0 0 0 0 0
Totale 12.077